Mourhaf Traboulssi, MD, is a cardiologist at University Hospitals Harrington Heart & Vascular Institute.
Dr. Traboulssi earned his medical degree from the Damascus University School of Medicine in Syria. His postdoctoral training began with an internal medicine residency at Al-Watony Hospital in Syria. He practiced as an internist for a few years before coming to the United States to complete an internal medicine residency and cardiology fellowship at the University of Louisville in Kentucky. He served as Chief Cardiology Fellow and was later inducted into Alpha Omega Alpha Medical Honor Society.
Dr. Traboulssi joined North Ohio Heart, Inc., in 1998 and has been in practice for more than 25 years. He is board certified in cardiovascular disease with additional certification in nuclear cardiology and forensics. He diagnoses and treats the full span of heart conditions, including coronary artery disease, congestive heart failure, heart rhythm disorders and heart valve disease.
Dr. Traboulssi is a member of multiple professional organizations including the American College of Medical Examiners, American Heart Association, National Arab American Medical Association and American College of Physicians. On a local level, he is a member of the Erie County Medical Society.
English, Arabic, French, German
Certifications & Memberships
- Cardiovascular Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Cardiology
Cardiology - University Hospital - University Of Louisville Healthcare (1994 - 1997)
Residency | Internal Medicine
Internal Medicine - University Hospital - University Of Louisville Healthcare (1991 - 1994)
University Of Damascus Faculty Of Medicine (1983)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Mourhaf Traboulssi did not disclose any Outside Relationships with Industry.